StockData
Davion Healthcare PLC logo

Davion Healthcare PLC (DAVI) shareholders

DAVINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Last filing: 20-F on Apr 30, 2026
$1.07+0.04 (+3.88%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Ownership

Who owns Davion Healthcare's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
2 buys · 0 sales
Net bought $27.47K

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Jack Harry Kaye10,268,94841.08%13D (active) amendmentAug 11, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jack Harry KayeCHIEF EXECUTIVE OFFICER, Director, 10% owner10,268,94841.08%Apr 17, 2026
Julian SluytersDirector30,0000.12%Nov 17, 2026
Susan M. KingDirector15,0000.06%Nov 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Susan M. King
Director
Nov 17, 2026Buy+10,000$0.10$98015,000
Julian Sluyters
Director
Nov 16, 2026Buy+25,000$1.06$26.49K30,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
1M shares short
Days to cover
1.0
At 2M shares a day
Change since last report
–
Short volume, 19 days
44.5%
Of volume reported to FINRA

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Davion Healthcare's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?